BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 1363616)

  • 21. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task.
    Ruotsalainen S; MacDonald E; Koivisto E; Stefanski R; Haapalinna A; Riekkinen P; Sirviö J
    J Psychopharmacol; 1998; 12(2):177-85. PubMed ID: 9694031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of fluoxetine given chronically on the responsiveness of 5-HT receptor subpopulations to their agonists.
    Maj J; Moryl E
    Eur Neuropsychopharmacol; 1993 Jun; 3(2):85-94. PubMed ID: 8364353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of intracerebroventricular administration of 5-HT receptor agonists on the maternal aggression of rats.
    De Almeida RM; Lucion AB
    Eur J Pharmacol; 1994 Nov; 264(3):445-8. PubMed ID: 7698186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats.
    Sánchez C; Mørk A
    Eur Neuropsychopharmacol; 1999 Jun; 9(4):287-94. PubMed ID: 10422888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats.
    Fone KC; Robinson AJ; Marsden CA
    Br J Pharmacol; 1991 Jun; 103(2):1547-55. PubMed ID: 1832068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroendocrine responses to the serotonin2 agonist DOI are differentially modified by three 5-HT1A agonists.
    Li Q; Rittenhouse PA; Levy AD; Alvarez Sanz MC; Van de Kar LD
    Neuropharmacology; 1992 Oct; 31(10):983-9. PubMed ID: 1359439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioural response to pharmacologic manipulation of serotonin receptors in the genetically dystonic hamster.
    Richter A; Löscher W
    Pharmacol Biochem Behav; 1995 Dec; 52(4):655-65. PubMed ID: 8587901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats.
    Krebs KM; Geyer MA
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):429-37. PubMed ID: 7862855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-HT1A and 5-HT1C/1D receptor agonists produce reciprocal effects on male sexual behavior of rhesus monkeys.
    Pomerantz SM; Hepner BC; Wertz JM
    Eur J Pharmacol; 1993 Oct; 243(3):227-34. PubMed ID: 8276074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective cross-tolerance to 5-HT1A and 5-HT2 receptor-mediated temperature and corticosterone responses.
    Nash JF; Meltzer HY; Gudelsky GA
    Pharmacol Biochem Behav; 1989 Aug; 33(4):781-5. PubMed ID: 2533356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of 5-HT1 and 5-HT2 serotonin receptors on anxiety- and depression-like behavior in female rats].
    Fedotova IuO
    Eksp Klin Farmakol; 2011; 74(3):6-9. PubMed ID: 21598629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats.
    Takao K; Nagatani T; Kitamura Y; Yamawaki S
    Eur J Pharmacol; 1997 Aug; 333(2-3):123-8. PubMed ID: 9314024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic, combined treatment with desipramine and mianserin: enhanced 5-HT1A receptor function and altered 5-HT1A/5-HT2 receptor interaction in rats.
    Lund A; Mjellem N
    Pharmacol Biochem Behav; 1993 Aug; 45(4):777-83. PubMed ID: 8415816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
    Johansson-Wallsten CE; Berg M; Meyerson BJ
    Eur J Pharmacol; 1993 Oct; 243(2):149-54. PubMed ID: 8276064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of isolation rearing on 5-HT agonist-induced responses in the rat.
    Wright IK; Ismail H; Upton N; Marsden CA
    Psychopharmacology (Berl); 1991; 105(2):259-63. PubMed ID: 1839066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-HT1A and 5-HT2 receptors mediate discrete behaviors in the Mongolian gerbil.
    Eison AS; Wright RN
    Pharmacol Biochem Behav; 1992 Sep; 43(1):131-7. PubMed ID: 1409796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
    Kitamura Y; Kitagawa K; Fujitani Y; Shibata K; Araki H; Sendou T; Gomita Y
    Biol Pharm Bull; 2007 Jan; 30(1):117-20. PubMed ID: 17202670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothalamic infusion of the 5-HT2/1C agonist, DOI, prevents the inhibitory actions of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Uphouse L; Andrade M; Caldarola-Pastuszka M; Maswood S
    Pharmacol Biochem Behav; 1994 Mar; 47(3):467-70. PubMed ID: 8208763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 5-HT2 receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane increases brain tryptophan levels in the rat.
    Chaouloff F; Baudrie V; Layeillon C; Broqua P
    Eur J Pharmacol; 1992 Apr; 214(1):101-3. PubMed ID: 1533838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.